Vol 52, No 2 (2021)
Short communication
Published online: 2021-04-29
Blood coagulation parameters and von Willebrand factor activity in critical stage COVID-19 patients
Acta Haematol Pol 2021;52(2):137-139.
Abstract
Not available
References
- Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020; 190: 62.
- Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7): 1017–1032.
- Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020; 18(7): 1738–1742.
- Yousuf B, Alsarraf AH, Alfoudri H. Acute ischemic stroke — an extrapulmonary COVID-19 presentation. Crit Care Shock. 2020; 23(4): 196–200.
- Xiao M, Zhang Y, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020; 382(17): e38–2004.
- Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020; 20(10): 1135–1140.
- Peyvandi F, Garagiola I, Baronciani L. Role of von Willebrand factor in the haemostasis. Blood Transfus. 2011; 9(Suppl 2): s3–s8.
- Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014; 58(5): 515–523.
